- Home
- TRT vs PASG Comparison
TRT vs PASG Comparison
Compare TRT & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- PASG
- Stock Information
- Founded
- TRT 1958
- PASG 2017
- Country
- TRT United States
- PASG United States
- Employees
- TRT N/A
- PASG N/A
- Industry
- TRT Industrial Machinery/Components
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- TRT Technology
- PASG Health Care
- Exchange
- TRT Nasdaq
- PASG Nasdaq
- Market Cap
- TRT 22.7M
- PASG 20.3M
- IPO Year
- TRT N/A
- PASG 2020
- Fundamental
- Price
- TRT $5.37
- PASG $7.18
- Analyst Decision
- TRT
- PASG Strong Buy
- Analyst Count
- TRT 0
- PASG 4
- Target Price
- TRT N/A
- PASG $59.25
- AVG Volume (30 Days)
- TRT 2.0K
- PASG 31.7K
- Earning Date
- TRT 09-22-2025
- PASG 08-12-2025
- Dividend Yield
- TRT N/A
- PASG N/A
- EPS Growth
- TRT N/A
- PASG N/A
- EPS
- TRT 0.00
- PASG N/A
- Revenue
- TRT $35,548,000.00
- PASG N/A
- Revenue This Year
- TRT N/A
- PASG N/A
- Revenue Next Year
- TRT N/A
- PASG N/A
- P/E Ratio
- TRT $1,218.93
- PASG N/A
- Revenue Growth
- TRT N/A
- PASG N/A
- 52 Week Low
- TRT $4.62
- PASG $5.12
- 52 Week High
- TRT $7.88
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- TRT 47.85
- PASG 53.33
- Support Level
- TRT $5.21
- PASG $6.65
- Resistance Level
- TRT $5.50
- PASG $7.54
- Average True Range (ATR)
- TRT 0.12
- PASG 0.56
- MACD
- TRT -0.01
- PASG 0.00
- Stochastic Oscillator
- TRT 33.33
- PASG 49.10
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.